ev3 Expanding Vascular Presence Via $95 Mil. IntraTherapeutics Acquisition

Private equity investor Warburg Pincus' ev3, Inc. unit is looking to build its peripheral vascular disease business through the purchase of Centerpulse subsidiary IntraTherapeutics for $95 mil. cash